NCT03796767 - Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

December 12, 2023

Study Completion Date

June 30, 2026

Conditions

Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph NodesOligometastasisProstate AdenocarcinomaPSA Failure

Interventions

RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated radiation therapy

RADIATION

Intensity-Modulated Radiation Therapy

Undergo IMRT

PROCEDURE

Metastasectomy

Undergo salvage oligometastasectomy

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

84112

Huntsman Cancer Institute/University of Utah, Salt Lake City

All Listed Sponsors

lead

University of Utah

OTHER